11.22.2019

Nov. 22, 2019 fibromyalgia and Lyme news

Nov. 22, 2019 news highlights: Biopharmaceutical company Aptinyx begins phase 2 trial for potential #fibromyalgia drug; #Lyme warrior launches company to link the chronically ill with employment opportunities; new study confirms many people with fibromyalgia have suffered past abuse; research shows naltrexone can repair immune cells of those with chronic fatigue syndrome; what we can learn from Germany about the opioid crisis and more! | Fed Up with Fatigue

1.

GlobeNewsWire.com: Aptinyx initiates two phase 2 studies of NYX-2925 in patients with chronic centralized pain conditions

From the article: “NYX-2925 is a novel NMDA receptor modulator that has been granted Fast Track designation by the U.S. Food and Drug Administration. The company expects to report data from … the fibromyalgia study in the first half of 2021.”

2.

Bostonia.com: Lyme disease set her back. And pushed her forward.

Boston University’s alumni magazine profiles Hannah Olson, a graduate who has chronic Lyme and has started a new company called Chronically Capable to help the chronically ill find employment opportunities.

3.

MedPage Today: Abuse in many fibromyalgia patients’ past

From the article: “Among nearly 600 patients seen at the Cleveland Clinic for fibromyalgia, 38% said they had been beaten, abused sexually, or both, said Carmen Gota, MD, at the American College of Rheumatology annual meeting.”

FYI: This website sometimes asks visitors to register to read their articles. Registration is completely free and does not require any sort of membership or payment.

4.

RawlsMD.com: Being “floxed” by antibiotics is especially risky to Lyme patients (YouTube video, 6 minutes)

From the article: “A new study links Cipro, Levaquin and other antibiotics in the fluoroquinolone family to scary side effects called ‘being floxed’ that are particularly damaging to Lyme patients.”

5.

MedicalXpress.com: Researchers discover potential therapeutic approach to treat chronic fatigue syndrome

From the article: “Researchers have discovered the pharmacological drug, naltrexone, significantly restored the function of faulty receptors associated with myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS).”

Note: I’m sharing this article since I know many of you are diagnosed with ME/CFS in addition to fibromyalgia or Lyme.

And an extra…

Pain News Network: What we can learn from Germany about the opioid crisis

From the article: “The story of Germany challenges much of the narrative about the American opioid crisis. If addiction moves in lockstep with opioid prescribing, then Germany should have high addiction rates. If prescription opioids lead to heroin use, then Germany should be seeing rising rates of heroin use. And if overdoses are an inevitable consequence of addiction, then Germany should have high overdose rates. But this is not what is happening.”

The Mitochondrial Summit…

Dr. Jay Davidson is hosting the free Mitochondrial Summit on Dec. 9-15. Mitochondrial health is an important topic for anyone with an energy-limiting illness since, in simple terms, the mitochondria are the power producers of our cells. Register here.

The sun is not our enemy…

Dr. Stephanie Seneff will be this week’s guest on Sound Health Radio on Sunday, Nov. 24, at 12 p.m. ET. She’ll discuss why the sun is not our enemy and how it plays a role in our health. Listen here!

Nov. 22, 2019 news highlights: Biopharmaceutical company Aptinyx begins phase 2 trial for potential #fibromyalgia drug; #Lyme warrior launches company to link the chronically ill with employment opportunities; new study confirms many people with fibromyalgia have suffered past abuse; research shows naltrexone can repair immune cells of those with chronic fatigue syndrome; what we can learn from Germany about the opioid crisis and more! | Fed Up with Fatigue

Comments

  1. It is really refreshing to see so much research taking place into chronic pain condition and fatigue. Its great that you put all this together so it is much easier for people to see all the articles in one place!

Speak Your Mind

*


This site uses Akismet to reduce spam. Learn how your comment data is processed.

Wordpress content guard plugin by JaspreetChahal.org